院外心脏骤停后神经预后临床预测模型:系统评价与Meta分析
该系统评价与Meta分析检索Medline和Embase至2025年6月1日,纳入39个观察性队列(95,037例)评估11种临床预测模型对院外心脏骤停后不良功能结局的预测性能。OHCA评分≥17汇总敏感度81.8%、特异度74.2%,≥32汇总敏感度64.9%、特异度89.5%(低确定性);CAHP评分≥150汇总敏感度81.3%、特异度77.0%(中等确定性)。11种模型汇总AUROC为0.75至0.88,异质性大。作者结论认为这些模型仅中等准确,限制其临床效用,尤其对撤除生命支持等不可逆决策。
要点
- OHCA评分≥17预测不良功能结局汇总敏感度81.8%(95%CI 65.8-91.4%)、特异度74.2%(95%CI 58.8-85.3%),证据确定性低。
- OHCA评分≥32汇总敏感度64.9%(95%CI 44.0-81.3%)、特异度89.5%(95%CI 75.9-95.8%),证据确定性低。
- CAHP评分≥150预测不良功能结局汇总敏感度81.3%(95%CI 77.7-84.4%)、特异度77.0%(95%CI 70.6-82.4%),证据确定性中等。
- 11种临床预测模型汇总AUROC为0.75至0.88,异质性大。
- 作者结论:预测模型仅中等准确且异质性大,限制其临床效用,尤其对撤除生命支持等不可逆决策。
适用人群与场景
- 成人院外心脏骤停患者,评估临床预测模型对不良功能结局的预测性能。
诊断标准与关键阈值
- OHCA评分≥17用于预测不良功能结局,汇总敏感度81.8%(95%CI 65.8-91.4%)、特异度74.2%(95%CI 58.8-85.3%),证据确定性低。
- OHCA评分≥32用于预测不良功能结局,汇总敏感度64.9%(95%CI 44.0-81.3%)、特异度89.5%(95%CI 75.9-95.8%),证据确定性低。
- CAHP评分≥150用于预测不良功能结局,汇总敏感度81.3%(95%CI 77.7-84.4%)、特异度77.0%(95%CI 70.6-82.4%),证据确定性中等。
研究设计与关键结果
- 系统评价与Meta分析纳入39个观察性队列共95,037例患者,评估11种临床预测模型。
- 最常见的两种评分为OHCA评分和CAHP评分。
- OHCA评分≥17预测不良功能结局汇总敏感度81.8%(95%CI 65.8-91.4%)、特异度74.2%(95%CI 58.8-85.3%),证据确定性低。
- OHCA评分≥32汇总敏感度64.9%(95%CI 44.0-81.3%)、特异度89.5%(95%CI 75.9-95.8%),证据确定性低。
- CAHP评分≥150汇总敏感度81.3%(95%CI 77.7-84.4%)、特异度77.0%(95%CI 70.6-82.4%),证据确定性中等。
- 11种临床预测模型汇总AUROC范围为0.75至0.88,异质性大。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,纳入39个观察性队列。
- 使用预测模型研究偏倚风险评估工具评估偏倚风险,使用GRADE评级证据确定性。
- OHCA评分相关结局证据确定性低,CAHP评分相关结局证据确定性中等。
- 局限:各验证队列间异质性大;作者结论认为预测模型仅中等准确,限制其临床效用,尤其对撤除生命支持等不可逆决策。
对床旁实践的改变
- 作者结论认为现有临床预测模型仅中等准确且异质性大,限制其临床效用,尤其对撤除生命支持等不可逆决策。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Summarize the prognostic performance of existing clinical prediction models (CPMs) for neuroprognostication after out-of-hospital cardiac arrest (OHCA).
DATA SOURCES: We searched Medline and Embase databases from inception to June 1, 2025.
STUDY SELECTION: We selected English-language studies that included adults with OHCA and evaluated a CPM for the prediction of poor functional outcome. We excluded derivation cohorts for prognostic scores and excluded models without at least two external validation cohorts.
DATA EXTRACTION: Two authors performed citation screening and data extraction. Where possible, we pooled the sensitivity and specificity of poor functional outcome, and the area under the receiver operating characteristic curve (AUROC) values for each CPM. We assessed risk of bias using the Prediction model study Risk of Bias Assessment Tool, and rated the certainty of evidence using the Grading of Recommendations, Assessment, Development, and Evaluation.
DATA SYNTHESIS: We included 39 observational cohorts (95,037 patients) evaluating 11 different CPMs, with the two most common scores being the OHCA and Cardiac Arrest Hospital Prognosis (CAHP) scores. An OHCA score greater than or equal to 17 had a pooled sensitivity of 81.8% (95% CI, 65.8-91.4%) and specificity of 74.2% (95% CI, 58.8-85.3%), while a score of greater than or equal to 32 had a pooled sensitivity of 64.9% (95% CI, 44.0-81.3%) and specificity of 89.5% (95% CI, 75.9-95.8%) for poor functional outcome (low certainty). A CAHP score greater than or equal to 150 had a pooled sensitivity of 81.3% (95% CI, 77.7-84.4%) and specificity of 77.0% (95% CI, 70.6-82.4%) for poor functional outcome (moderate certainty). Pooled AUROCs across the 11 CPMs varied from 0.75 to 0.88, with substantial heterogeneity.
CONCLUSIONS: CPMs for neuroprognostication after OHCA demonstrate only moderate accuracy, with substantial heterogeneity across validation cohorts. These limitations restrict their clinical utility, particularly for irreversible decisions such as withdrawal of life-sustaining therapy.
参考来源
- Niznick N, Sadeghirad B, Rochwerg B, et al. Clinical Prediction Models for Prognostication After Out-of-Hospital Cardiac Arrest: A Systematic Review and Meta-Analysis. Crit Care Med. 2026. PMID: 42274294. doi:10.1097/CCM.0000000000007206
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。